Healthcare Global Enterprises Limited · NSE: HCG · BSE: 539787
Healthcare Global Enterprises
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 06 Aug 2026.
Q1 FY27 · Consolidated
Revenue
695.10₹ Cr
+13.4% vs year ago
Net profit
16.46₹ Cr
+175.3% vs year ago
EPS, basic
0.92₹
+170.6% vs year ago
Net margin
2.4%
+1.4 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 695.10 | +13.4% | 16.46 | +175.3% | 0.92 | 06 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 652.33 | +11.5% | 4.04 | −40.3% | 0.15 | 19 May 2026 |
| Q3 FY26Oct–Dec 2025 | 633.07 | +13.5% | (7.90) | Turned loss | (0.68) | 05 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 646.85 | +16.9% | 20.66 | −0.1% | 1.16 | 12 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 613.16 | +16.7% | 5.98 | −56.1% | 0.34 | 01 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 585.16 | +18.3% | 6.77 | −71.1% | 0.53 | 24 May 2025 |
| Q3 FY25Oct–Dec 2024 | 557.55 | +18.7% | 7.75 | +125.9% | 0.50 | 14 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 553.54 | +13.7% | 20.68 | +91.8% | 1.29 | 09 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 525.58 | +14.1% | 13.63 | +273.4% | 0.87 | 23 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 494.63 | +12.0% | 23.46 | +315.2% | 1.53 | 11 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 469.87 | +10.6% | 3.43 | −18.3% | 0.41 | 20 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 486.94 | +15.9% | 10.78 | +103.8% | 0.97 | 22 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 460.68 | +12.9% | 3.65 | +47.2% | 0.55 | 10 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 441.71 | +21.1% | 5.65 | +151.1% | 0.60 | 25 May 2023 |
| Q3 FY23Oct–Dec 2022 | 424.68 | +18.6% | 4.20 | Turned profit | 0.54 | 10 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 420.00 | +19.3% | 5.29 | −94.7% | 0.53 | 11 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 408.05 | +26.3% | 2.48 | Turned profit | 0.44 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 364.63 | +22.3% | 2.25 | Turned profit | 0.43 | 27 May 2022 |
| Q3 FY22Oct–Dec 2021 | 358.06 | +30.7% | (49.80) | Loss widened | (3.55) | 10 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 351.96 | +42.0% | 98.99 | Turned profit | 8.22 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 323.14 | +67.0% | (12.52) | Loss narrowed | (0.76) | 12 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 298.05 | +10.2% | (113.76) | Loss widened | (8.14) | 18 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 274.01 | −1.4% | (34.73) | Loss widened | (2.33) | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 247.92 | −11.0% | (26.56) | Loss widened | (1.94) | 19 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 193.46 | −28.0% | (45.61) | Loss widened | (4.48) | 21 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 270.37 | +5.2% | (50.44) | Loss widened | (4.91) | 29 Jul 2020 |
| Q3 FY20Oct–Dec 2019 | 277.93 | +11.7% | (29.16) | Loss widened | (2.57) | 14 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 278.46 | +13.5% | (25.26) | Loss widened | (2.51) | 13 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 268.88 | +18.7% | (20.59) | Loss widened | (2.05) | 09 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 257.10 | — | (10.88) | — | (0.99) | 28 May 2019 |
| Q3 FY19Oct–Dec 2018 | 248.87 | — | (6.03) | — | (0.71) | 08 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 245.32 | — | (7.64) | — | (0.74) | 12 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 226.56 | — | (6.33) | — | (0.39) | 13 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 376.66 | +15.2% | 5.58 | +61.7% | 0.37 | 06 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 350.21 | +8.0% | 1.53 | −84.9% | 0.11 | 19 May 2026 |
| Q3 FY26Oct–Dec 2025 | 342.16 | +9.8% | (1.18) | Loss narrowed | (0.08) | 05 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 345.84 | +12.8% | 10.78 | −32.8% | 0.77 | 12 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 327.09 | +11.4% | 3.45 | −70.6% | 0.25 | 01 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 324.39 | +15.7% | 10.16 | Turned profit | 0.73 | 24 May 2025 |
| Q3 FY25Oct–Dec 2024 | 311.67 | +16.6% | (37.33) | Turned loss | (2.68) | 14 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 306.67 | +8.5% | 16.03 | +17.0% | 1.15 | 09 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 293.61 | +7.9% | 11.72 | −14.4% | 0.84 | 23 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 280.38 | +8.4% | (1.76) | Turned loss | (0.13) | 11 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 267.21 | +5.8% | 8.33 | −41.2% | 0.60 | 20 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 282.75 | +11.7% | 13.70 | +24.5% | 0.98 | 22 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 272.23 | +12.0% | 13.69 | +26.2% | 0.98 | 10 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 258.67 | +17.5% | 4.18 | Turned profit | 0.30 | 25 May 2023 |
| Q3 FY23Oct–Dec 2022 | 252.68 | +17.2% | 14.16 | Turned profit | 1.02 | 10 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 253.07 | +17.3% | 11.00 | −88.3% | 0.79 | 11 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 243.17 | +21.2% | 10.85 | +675.0% | 0.78 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 220.19 | +22.7% | (17.92) | Loss narrowed | (1.29) | 27 May 2022 |
| Q3 FY22Oct–Dec 2021 | 215.51 | +31.4% | (39.13) | Loss widened | (3.03) | 10 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 215.66 | +48.2% | 93.90 | Turned profit | 7.49 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 200.60 | +64.6% | 1.40 | Turned profit | 0.11 | 12 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 179.51 | +4.4% | (153.22) | Loss widened | (12.20) | 18 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 164.06 | −5.2% | (13.01) | Loss widened | (1.04) | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 145.56 | −16.2% | (6.58) | Loss widened | (0.57) | 19 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 121.90 | −28.7% | (18.73) | Loss widened | (2.11) | 21 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 171.99 | +3.9% | (43.55) | Turned loss | (4.91) | 29 Jul 2020 |
| Q3 FY20Oct–Dec 2019 | 172.98 | +8.3% | (4.27) | Loss widened | (0.48) | 14 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 173.71 | +7.4% | (3.47) | Turned loss | (0.39) | 13 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 170.89 | +10.9% | (2.01) | Turned loss | (0.23) | 09 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 165.61 | — | 3.03 | — | 0.35 | 28 May 2019 |
| Q3 FY19Oct–Dec 2018 | 159.67 | — | (0.18) | — | (0.02) | 08 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 161.67 | — | 1.09 | — | 0.12 | 12 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 154.16 | — | 3.31 | — | 0.38 | 13 Aug 2018 |
66 filings on record for this company.